Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Amygdalin promotes the activity of T cells to suppress the progression of HBV-related hepatocellular carcinoma via the JAK2/STAT3 signaling pathway

Fig. 1

Effect of amygdalin on normal (NC-T) and HBV-related HCC T cells (HBV-T). a T cells isolated from the peripheral blood from healthy donors (NC-T) were stimulated with 5 μg/ml Con A and treated with a series of doses of amygdalin (0, 5, 10, 15, and 20 μg/ml) and examined for cell viability using MTT assay. b The cell viability of NC-T and T cells isolated from the peripheral blood from HBV-related HCC patients (HBV-T) was examined by MTT assay with or without amygdalin treatment (10 μg/ml). c-f The production of IFN-γ, TNF-α, IL-6, and IL-10 in NC-T and HBV-T cells was determined by ELISA with or without amygdalin treatment (10 μg/ml). n = 5, *p < 0.05, **p < 0.01, ***p < 0.001, compared to NC-T group, #p < 0.05, ##p < 0.01, ###p < 0.001, compared to HBV-T group

Back to article page